title: [Acute drug-induced hepatitis during adalimumab and ibuprofen treatment].
authors.forename: S
authors.initials: S
authors.lastname: Féau
authors.forename: X
authors.initials: X
authors.lastname: Causse
authors.forename: A
authors.initials: A
authors.lastname: Corondan
authors.forename: P
authors.initials: P
authors.lastname: Michenet
authors.forename: E
authors.initials: E
authors.lastname: Autret-Leca
mesh_terms: D000068879:Adalimumab; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab; D007052:Ibuprofen